This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Ghent. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Martijn Risseeuw: Innovator in Pharmaceutical Compositions
Introduction
Martijn Risseeuw is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on hamamelitannin analogues. His research focuses on developing compounds that can be utilized in both human and veterinary medicine.
Latest Patents
Martijn Risseeuw holds a patent for "Hamamelitannin analogues and uses thereof." This invention relates to hamamelitannin analogues, pharmaceutical compositions comprising these compounds, and their combinations with anti-microbial agents such as antibiotics or disinfectants. The patent emphasizes the use of these compounds in the prevention and treatment of bacterial infections in humans and animals.
Career Highlights
Risseeuw is affiliated with the University of Ghent, where he conducts his research and development activities. His work has garnered attention for its potential applications in medical treatments, showcasing his commitment to advancing healthcare solutions.
Collaborations
Some of his notable coworkers include Gilles Brackman and Tom Coenye. Their collaborative efforts contribute to the innovative research environment at the University of Ghent.
Conclusion
Martijn Risseeuw's contributions to pharmaceutical compositions and his innovative patent highlight his role as a key figure in the field. His work not only advances scientific knowledge but also has the potential to improve medical treatments for various infections.